Also called: KPV + BPC-157 Gut Healing Stack, Lys-Pro-Val, Lysine-Proline-Valine
KPV is a very small protein piece, called a peptide, that comes from a bigger body protein involved in calming swelling. It is sold by research chemical companies for lab study only. It is not an approved medicine. People who are curious about healing and soothing inflammation sometimes look it up online.
In lab studies, KPV seems to calm the body's swelling response. Swelling is how the body fights injury, but too much swelling hurts and slows healing. KPV can slip into cells and turn down the alarm signals that cause redness, heat, and pain. Researchers have mainly studied this in animals and in cells, looking at skin wounds and gut irritation.
Much is still unknown. There is little strong testing in people, so doctors cannot say it works or is safe for any health problem. An FDA advisory group has talked about whether it could be allowed in special pharmacy-made medicines, but that is not an approval. It should not be taken without a doctor's care.
Building Blocks
KPV is one of the building blocks in this blend or stack people actually buy:
On July 23, 2026, PCAC voted 8–6–1 to recommend adding KPV to the Section 503A Bulks List. The vote is advisory — FDA is not bound by it and must complete formal rulemaking before KPV could be lawfully compounded under 503A. KPV is not currently on the 503A Bulks List, remains an unapproved new drug, and may not be lawfully compounded by traditional 503A pharmacies in the interim.
Benefits
The main themes across 37 research studies, in plain language.
Research suggests KPV may significantly reduce intestinal inflammation and support the management of inflammatory bowel conditions like colitis.
Research indicates KPV may utilize the PepT1 transporter to target the gut, helping to restore tight junctions and protect the intestinal lining.
Evidence suggests KPV may accelerate wound closure, support collagen synthesis, and enhance the repair of skin and mucosal tissues.
Studies indicate that KPV may inhibit key inflammatory pathways (NF-κB, MAPK) and lower pro-inflammatory cytokines throughout the body.
Research suggests KPV may help regulate immune responses and reduce autoimmune activity without causing broad immunosuppression.
Studies suggest KPV may possess antimicrobial properties that help combat specific bacteria and fungi, such as Staphylococcus aureus.
Research suggests KPV may help lower oxidative stress markers and protect cells from free radical damage.
Preliminary research indicates potential for protecting the brain and reducing neuroinflammation following injury or in states of brain fog.
Research points to potential benefits for inflammatory skin issues, including psoriasis, eczema, and redness, without causing pigmentation changes.
Animal studies suggest KPV may help reduce the risk of tumor development specifically associated with chronic colitis.
See where KPV fits — the most-used combinations, dosing notes from the research, and what to check before you buy.
No spam. Unsubscribe anytime.
1 reported routine — each line links to the source it came from.
From published sources
Routines as reported in peer-reviewed papers, clinical guidance, or vetted media — each linked to the source it came from.
SubQ
mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Evidence
Every claim above traces back to a source you can check — here are 4 of them.
Structural modification of the tripeptide KPV by reductive "glycoalkylation" of the lysine residue.
kpv
A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon
KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification Therapy
Timeline
Key moments in KPV’s research and regulatory timeline — sourced and dated.
Wondering how KPV pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →Explore by goal
Related peptides
Compare
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.